Auto-Injectors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Market Overview

Global Auto-Injectors market is expected to witness a CAGR of 20.7% during the forecast period. Certain factors that are driving the market growth include increasing demand for the convenience of patients, rising incidence of chronic and lifestyle diseases, and technological advancements.

The use of auto-injector has brought many benefits for both the patient and healthcare professional. It has simplified self-administration, reduced anxiety, improved safety, and improved compliance. For instance, most of the currently available disease-modifying therapies available in the market for the treatment of multiple sclerosis are administered through injection. This has always been considered as a source of fear for a large number of patients and a considerable cause of non-adherence to treatment. Autoinjectors can address this issue by ensuring that the injection is made at the accurate depth and can distinctly improve the comfort and tolerability of administration when compared to manual syringes. Data from various clinical trials support the use of autoinjectors presenting that they improve adherence and the smaller gauge needles significantly reduce injection discomfort.

Scope of the Report

Auto-Injector refers to a syringe which contains a spring-loaded needle generally with a preloaded dose of medication. Upon being forced against the body with a piercing motion, the device gets activated and administers a calculated dose of medication. Autoinjectors are usually used for self-administration of epinephrine (in order to mitigate anaphylaxis); by migraine sufferers who want to achieve quick relief of headache; or even by military as well as emergency services workers in order to combat the effects of nerve agents.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Rheumatoid Arthritis is Expected to Hold Significant Market Share in the Application Segment

Rheumatoid arthritis (RA) is a chronic autoimmune disorder in which the joints are attacked by the body’s immune system and inflammation of the synovium is created, causing swelling and pain in and around the joints. The RA Organisation, US, states that the disease affects over 1.3 million Americans and as much as 1% of the worldwide population (as of 2018). 

According to several recent studies, majority of the patients with rheumatoid arthritis who used an autoinjector for the treatment were observed to be comfortable using the device and even had better outcomes than those who had someone else administer injections.

To understand key trends, Download Sample Report